Close An early clinical trial recently showed that the new Moderna COVID-19 booster could be an effective shield against the variants of coronavirus originally found in South Africa and Brazil. According to ScienceAlert, the American biotech company began to develop "variant-specific boosters" earlier this year after evidence that several variants of COVID-19 can break through present vaccines. This is Moderna's pioneering clinical trial in humans, following early trials on mice, and so far, the results are found promising. Stephen Bancel, Moderna CEO said in a press release the company poste...